Atlas Trials

Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI Patients

Clinical trial NCT05957887 · UNKNOWN

Trial details

NCT number
NCT05957887
Sponsor
Mohamed Nabil Elkholy
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
STEMI
Start date
2022-04-15
Primary completion
2025-03-15
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.